Economic Development

Medpace continues European expansion

Business Courier of Cincinnati

Medpace continued its European expansion with the acquisition of Medical Consulting Dr. Schlichtiger GmbH, a German drug research firm.

Medical Consulting is based in Munich and provides customized regulatory and side-effect monitoring services to pharmaceutical, biotechnology, and nutritional companies of all sizes. Financial details of the sale were not disclosed.

The privately held German firm is led by Dr. Ursula Schlichtiger, general manager, a research professional with extensive experience in clinical development, regulatory affairs, and pharmacovigilance, or the detection and prevention of adverse side-effects in drugs. Schlichtiger will join Medpace as managing director and senior director of medical and regulatory affairs, Europe.

“I am pleased to have Dr. Schlichtiger join the Medpace team to support our growing presence in the European drug development market, said Dr. August Troendle, president and CEO of Medpace, in a news release. “Dr. Schlichtiger has built a reputation in Europe as a distinguished professional having founded Medical Consulting in 1989 and built the company into an organization widely recognized for its successful interaction with European governmental agencies.”

The integration of Medical Consulting Dr. Schlichtiger GmbH will begin immediately with the goal of completion by mid-2010.

Medpace also acquired the Swiss firm Pharma Brains AG, a clinical research organization that focuses on oncology, in November.

Medpace, provides Phase I-IV clinical trial services worldwide.

To view the Business Courier article click here

On January 14, 2010, Al Neyer, Inc. broke ground for a new 132,000 sq. ft. Medpace Global Headquarters in Cincinnati, Ohio.

Medpace anticipates they will occupy 350,000 sq. ft. of new office space by 2014. The company will continue to maintain a presence at their Norwood location until their final lease ends in 2013. They will move employees to the new Cincinnati campus over 5 years.